PRKAA2 and metabolic disease: The novel NFE2L1/AMPK signaling pathway discovered in this study not only revealed the underlying mechanism of NFE2L1-related metabolic diseases but also highlight the crosstalk between redox homeostasis and metabolism homeostasis.